Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion type Assertion NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_head.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion evidence source_evidence_literature NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion SIO_000772 23386689 NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion wasDerivedFrom befree-20150227 NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.
- NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_assertion wasGeneratedBy ECO_0000203 NP553972.RAHocBnOTOrJbtf1lO3t9yaAvOv7-biKYxEWXZGEz3S6A130_provenance.